Variant report
Variant | nsv1014030 |
---|---|
Chromosome Location | chr4:96721030-96735608 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11946552 | chr4:96721030-96721031 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs569943862 | chr4:96721031-96721032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187354941 | chr4:96721144-96721145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112535530 | chr4:96721154-96721155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192353550 | chr4:96721181-96721182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144004929 | chr4:96721187-96721188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528364893 | chr4:96721189-96721190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368626517 | chr4:96721201-96721202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546533485 | chr4:96721206-96721207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541753205 | chr4:96721255-96721256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183733347 | chr4:96721322-96721323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28618209 | chr4:96721346-96721347 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs574339178 | chr4:96721354-96721355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543069839 | chr4:96721360-96721361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562982271 | chr4:96721376-96721377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531876917 | chr4:96721436-96721437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17471302 | chr4:96721451-96721452 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs28526484 | chr4:96721499-96721500 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs568833008 | chr4:96721500-96721501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73839634 | chr4:96721533-96721534 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs79153412 | chr4:96721579-96721580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567676954 | chr4:96721581-96721582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144043778 | chr4:96721590-96721591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372823025 | chr4:96721597-96721598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs188701297 | chr4:96721659-96721660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377302608 | chr4:96721662-96721663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190604914 | chr4:96721665-96721666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs62306995 | chr4:96721666-96721667 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs182838668 | chr4:96721692-96721693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs367805813 | chr4:96721698-96721699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552502229 | chr4:96721713-96721714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143225564 | chr4:96721721-96721722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534531425 | chr4:96721729-96721730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554618068 | chr4:96721730-96721731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187085031 | chr4:96721731-96721732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146607242 | chr4:96721733-96721734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191571907 | chr4:96721773-96721774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576434710 | chr4:96721774-96721775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574396306 | chr4:96721801-96721802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149203474 | chr4:96721808-96721809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563708857 | chr4:96721826-96721827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372717899 | chr4:96721921-96721922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7680705 | chr4:96721935-96721936 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs375976469 | chr4:96721947-96721948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182926178 | chr4:96721958-96721959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187514249 | chr4:96721970-96721971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369949661 | chr4:96721987-96721988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs193258580 | chr4:96722019-96722020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143336498 | chr4:96722045-96722046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374300824 | chr4:96722127-96722128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:96720000-96721200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr4:96721000-96721200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr4:96721000-96721400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr4:96721400-96722400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
5 | chr4:96722200-96723400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr4:96722200-96723600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr4:96722400-96724200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
8 | chr4:96734200-96736200 | Enhancers | Adipose Nuclei | Adipose |